Your browser doesn't support javascript.
loading
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.
Galluzzi, L; Bravo-San Pedro, J M; Vitale, I; Aaronson, S A; Abrams, J M; Adam, D; Alnemri, E S; Altucci, L; Andrews, D; Annicchiarico-Petruzzelli, M; Baehrecke, E H; Bazan, N G; Bertrand, M J; Bianchi, K; Blagosklonny, M V; Blomgren, K; Borner, C; Bredesen, D E; Brenner, C; Campanella, M; Candi, E; Cecconi, F; Chan, F K; Chandel, N S; Cheng, E H; Chipuk, J E; Cidlowski, J A; Ciechanover, A; Dawson, T M; Dawson, V L; De Laurenzi, V; De Maria, R; Debatin, K-M; Di Daniele, N; Dixit, V M; Dynlacht, B D; El-Deiry, W S; Fimia, G M; Flavell, R A; Fulda, S; Garrido, C; Gougeon, M-L; Green, D R; Gronemeyer, H; Hajnoczky, G; Hardwick, J M; Hengartner, M O; Ichijo, H; Joseph, B; Jost, P J.
Afiliação
  • Galluzzi L; 1] Gustave Roussy Cancer Center, Villejuif, France [2] Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France [3] Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France.
  • Bravo-San Pedro JM; 1] Gustave Roussy Cancer Center, Villejuif, France [2] Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France [3] INSERM, U1138, Gustave Roussy, Paris, France.
  • Vitale I; Regina Elena National Cancer Institute, Rome, Italy.
  • Aaronson SA; Department of Oncological Sciences, The Tisch Cancer Institute, Ichan School of Medicine at Mount Sinai, New York, NY, USA.
  • Abrams JM; Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Adam D; Institute of Immunology, Christian-Albrechts University, Kiel, Germany.
  • Alnemri ES; Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Altucci L; Dipartimento di Biochimica, Biofisica e Patologia Generale, Seconda Università degli Studi di Napoli, Napoli, Italy.
  • Andrews D; Department of Biochemistry and Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Annicchiarico-Petruzzelli M; Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata - Istituto Ricovero Cura Carattere Scientifico (IDI-IRCCS), Rome, Italy.
  • Baehrecke EH; Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Bazan NG; Neuroscience Center of Excellence, School of Medicine, New Orleans, LA, USA.
  • Bertrand MJ; 1] VIB Inflammation Research Center, Ghent, Belgium [2] Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Bianchi K; 1] Barts Cancer Institute, Cancer Research UK Centre of Excellence, London, UK [2] Queen Mary University of London, John Vane Science Centre, London, UK.
  • Blagosklonny MV; Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Blomgren K; Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Borner C; Institute of Molecular Medicine and Spemann Graduate School of Biology and Medicine, Albert-Ludwigs University, Freiburg, Germany.
  • Bredesen DE; 1] Buck Institute for Research on Aging, Novato, CA, USA [2] Department of Neurology, University of California, San Francisco (UCSF), San Francisco, CA, USA.
  • Brenner C; 1] INSERM, UMRS769, Châtenay Malabry, France [2] LabEx LERMIT, Châtenay Malabry, France [3] Université Paris Sud/Paris XI, Orsay, France.
  • Campanella M; Department of Comparative Biomedical Sciences and Consortium for Mitochondrial Research, University College London (UCL), London, UK.
  • Candi E; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Cecconi F; 1] Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, Rome, Italy [2] Department of Biology, University of Rome Tor Vergata; Rome, Italy [3] Unit of Cell Stress and Survival, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Chan FK; Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Chandel NS; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Cheng EH; Human Oncology and Pathogenesis Program and Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA.
  • Chipuk JE; Department of Oncological Sciences, The Tisch Cancer Institute, Ichan School of Medicine at Mount Sinai, New York, NY, USA.
  • Cidlowski JA; Laboratory of Signal Transduction, National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), North Carolina, NC, USA.
  • Ciechanover A; Tumor and Vascular Biology Research Center, The Rappaport Faculty of Medicine and Research Institute, Technion Israel Institute of Technology, Haifa, Israel.
  • Dawson TM; 1] Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering (ICE), Departments of Neurology, Pharmacology and Molecular Sciences, Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA [2] Adrienne Helis Malvin Medical Research Fo
  • Dawson VL; 1] Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering (ICE), Departments of Neurology, Pharmacology and Molecular Sciences, Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA [2] Adrienne Helis Malvin Medical Research Fo
  • De Laurenzi V; Department of Experimental and Clinical Sciences, Gabriele d'Annunzio University, Chieti, Italy.
  • De Maria R; Regina Elena National Cancer Institute, Rome, Italy.
  • Debatin KM; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
  • Di Daniele N; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Dixit VM; Department of Physiological Chemistry, Genentech, South San Francisco, CA, USA.
  • Dynlacht BD; Department of Pathology and Cancer Institute, Smilow Research Center, New York University School of Medicine, New York, NY, USA.
  • El-Deiry WS; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medicine (Hematology/Oncology), Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
  • Fimia GM; 1] Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy [2] Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani, Istituto Ricovero Cura Carattere Scientifico (IRCCS), Rome,
  • Flavell RA; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
  • Fulda S; Institute for Experimental Cancer Research in Pediatrics, Goethe University, Frankfurt, Germany.
  • Garrido C; 1] INSERM, U866, Dijon, France [2] Faculty of Medicine, University of Burgundy, Dijon, France.
  • Gougeon ML; Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Institut Pasteur, Paris, France.
  • Green DR; Department of Immunology, St Jude's Children's Research Hospital, Memphis, TN, USA.
  • Gronemeyer H; Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
  • Hajnoczky G; Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Hardwick JM; W Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.
  • Hengartner MO; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
  • Ichijo H; Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
  • Joseph B; Department of Oncology-Pathology, Cancer Centrum Karolinska (CCK), Karolinska Institute, Stockholm, Sweden.
  • Jost PJ; Medical Department for Hematology, Technical University of Munich, Munich, Germany.
Cell Death Differ ; 22(1): 58-73, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25236395
ABSTRACT
Cells exposed to extreme physicochemical or mechanical stimuli die in an uncontrollable manner, as a result of their immediate structural breakdown. Such an unavoidable variant of cellular demise is generally referred to as 'accidental cell death' (ACD). In most settings, however, cell death is initiated by a genetically encoded apparatus, correlating with the fact that its course can be altered by pharmacologic or genetic interventions. 'Regulated cell death' (RCD) can occur as part of physiologic programs or can be activated once adaptive responses to perturbations of the extracellular or intracellular microenvironment fail. The biochemical phenomena that accompany RCD may be harnessed to classify it into a few subtypes, which often (but not always) exhibit stereotyped morphologic features. Nonetheless, efficiently inhibiting the processes that are commonly thought to cause RCD, such as the activation of executioner caspases in the course of apoptosis, does not exert true cytoprotective effects in the mammalian system, but simply alters the kinetics of cellular demise as it shifts its morphologic and biochemical correlates. Conversely, bona fide cytoprotection can be achieved by inhibiting the transduction of lethal signals in the early phases of the process, when adaptive responses are still operational. Thus, the mechanisms that truly execute RCD may be less understood, less inhibitable and perhaps more homogeneous than previously thought. Here, the Nomenclature Committee on Cell Death formulates a set of recommendations to help scientists and researchers to discriminate between essential and accessory aspects of cell death.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Apoptose Limite: Animals / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Apoptose Limite: Animals / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França